Feldan Therapeutics Overview

  • Founded

  • 2007

Founded
  • Status

  • Private

  • Employees

  • 36

Employees
  • Latest Deal Type

  • Series A

  • Latest Deal Amount

  • $13.8M

  • Investors

  • 7

Feldan Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to specialize in the development of treatments based on the intracellular delivery of therapeutics. The company's technology unlocks the development of a new generation of treatments by giving access to intracellular components beyond the reach of existing drugs, enabling the safe and efficient delivery of various compounds inside cells.

Contact Information

Website
www.feldan.com
Formerly Known As
Feldan Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 2666 Boulevard Du Parc Technologique
  • Suite 290
  • Quebec, Quebec G1P 4S6
  • Canada
+1 (418) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Feldan Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 18-Sep-2018 $13.8M 000.00 Completed Pre-Clinical Trials
3. Later Stage VC 01-Apr-2017 000 00.000 Completed Pre-Clinical Trials
2. Later Stage VC 05-Oct-2015 $1.7M $2.08M Completed Pre-Clinical Trials
1. Angel (individual) 28-Sep-2011 $385K $385K Completed Pre-Clinical Trials
To view Feldan Therapeutics’s complete valuation and funding history, request access »

Feldan Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to specialize in the development of treatments based on the intracellul
Biotechnology
Quebec, Canada
36 As of 2023
000.00
00000000000 000.00

000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
000000000000000
Plankstadt, Germany
0000 As of 0000
000000000000

000 00

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000 000000000
Nedlands, Australia
00 As of 0000
0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Feldan Therapeutics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CordenPharma Private Equity-Backed Plankstadt, Germany 0000 000000000000
000 000000000000 Formerly VC-backed Nedlands, Australia 00 0000 000000000 0000
0000000 0000000000 Corporate Backed or Acquired Leiden, Netherlands 000 000000&0
000000000 Venture Capital-Backed Berlin, Germany 00 00000 0000000000 0 00000
0000000 0000000000 Formerly VC-backed Boston, MA 000 00000 00000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Feldan Therapeutics Patents

  • 35

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 5

    Pending

  • 000

    Expiring in next 12 mo

Feldan Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021366976-A1 Shuttle agent peptides of minimal length and variants thereof adapted for transduction of cas9-rnp and other nucleoprotein cargos Pending 22-Oct-2021
AU-2021362834-A1 Peptide-based transduction of non-anionic polynucleotide analogs for gene expression modulation Pending 18-Oct-2021
CA-3196066-A1 Shuttle agent peptides of minimal length and variants thereof adapted for transduction of cas9-rnp and other nucleoprotein cargos Pending 22-Oct-2020 000000000
CA-3195442-A1 Peptide-based transduction of non-anionic polynucleotide analogs for gene expression modulation Pending 18-Oct-2020 000000000
AU-2020260283-A1 Peptide-based non-proteinaceous cargo delivery Pending 18-Apr-2019 C07K7/08
To view Feldan Therapeutics’s complete patent history, request access »

Feldan Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Francois-Thomas Michaud Ph.D Co-Founder, Chief Executive Officer & Board Member
Vincent Ménard Ph.D Vice President of Finance & Business Development
You’re viewing 2 of 3 executive team members. Get the full list »

Feldan Therapeutics Board Members (15)

Name Representing Role Since
Benoit Cyr Anges Québec Executive Chairman 000 0000
David Mazzo Ph.D Self Board Member 000 0000
Francois-Thomas Michaud Ph.D Feldan Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Hyun-Ki Kim Stonebridge Ventures Board Member 000 0000
Iain Dukes Ph.D Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Feldan Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Feldan Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Asahi Kasei Corporate Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
GC Biopharma Corporation Minority 000 0000 000000 0
Groupe Roski Venture Capital Minority 000 0000 000000 0
Novateur Ventures Venture Capital Minority 000 0000 000000 0
Stonebridge Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial